Add Formweb to your mobile device
Search results for:
clindamycin
clindamycin
| Drug Name | Form | Strength | Notes |
|---|---|---|---|
| Clindamycin | CAPSULE, ORAL | 150 mg | |
| Clindamycin | CAPSULE, ORAL | 300 mg | |
| Clindamycin Palmitate | POWDER FOR RECONSTITUTION, ORAL | 75 mg/5 mL | |
| Cleocin Phosphate | SOLUTION, INJECTABLE | 150 mg/mL | |
| Clindamycin Phosphate | SOLUTION, INJECTABLE | 150 mg/mL | |
| Cleocin Phosphate | SOLUTION, INTRAVENOUS | 600 mg-5%/50 mL | |
| Cleocin Phosphate | SOLUTION, INTRAVENOUS | 900 mg-5%/50 mL |
Last updated: Nov. 30, 2021
- RCRA: Disposal
- RCRA: Management of Pharmaceutical Waste Policy
- Black Box Warning: Pseudomembranous colitis
Clindamycin
Intravenous (IV) orders will be automatically converted to enteral (PO) product for eligible patients. See Protocol 916.6007
Randall Children’s Hospital Suspected Bacterial Sepsis/Meningitis: Pharmacy Guidelines (pediatric only)